RECON Trademark

Trademark Overview


On Friday, October 28, 2016, a trademark application was filed for RECON with the United States Patent and Trademark Office. The USPTO has given the RECON trademark a serial number of 87977717. The federal status of this trademark filing is REGISTERED as of Tuesday, July 10, 2018. This trademark is owned by Neon Therapeutics, Inc.. The RECON trademark is filed in the Computer & Software Services & Scientific Services and Medical & Beauty Services & Agricultural Services categories with the following description:

Medical and pharmaceutical consultation; and providing information relating to therapeutic properties of pharmaceuticals

Conducting early evaluations in the field of new pharmaceuticals; consulting services in the fields of biotechnology and pharmaceutical research; pharmaceutical product development services; pharmaceutical product evaluation services; pharmaceutical research and development; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; research and development of pharmaceuticals for the treatment of cancer; research and development of vaccines and medicines; technical research in the field of pharmaceutical studies; development of platform technology, namely, cancer immunotherapy platforms for manufacturing therapeutics; conducting clinical trials for others in the field of pharmaceuticals for the treatment and prevention of cancer; and consulting services for others in the field of design, planning, and implementation of clinical trials
recon

General Information


Serial Number87977717
Word MarkRECON
Filing DateFriday, October 28, 2016
Status700 - REGISTERED
Status DateTuesday, July 10, 2018
Registration Number5515643
Registration DateTuesday, July 10, 2018
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 26, 2017

Trademark Statements


Amendment to a Registration/Renewal CertificateIssue New Certificate to: BioNTech US Inc. (Delaware corporation) 40 Erie Street, Suite 110, Cambridge MA 02139.
Goods and ServicesMedical and pharmaceutical consultation; and providing information relating to therapeutic properties of pharmaceuticals
Goods and ServicesConducting early evaluations in the field of new pharmaceuticals; consulting services in the fields of biotechnology and pharmaceutical research; pharmaceutical product development services; pharmaceutical product evaluation services; pharmaceutical research and development; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; research and development of pharmaceuticals for the treatment of cancer; research and development of vaccines and medicines; technical research in the field of pharmaceutical studies; development of platform technology, namely, cancer immunotherapy platforms for manufacturing therapeutics; conducting clinical trials for others in the field of pharmaceuticals for the treatment and prevention of cancer; and consulting services for others in the field of design, planning, and implementation of clinical trials

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, November 2, 2016
Primary Code042
First Use Anywhere DateMonday, January 23, 2017
First Use In Commerce DateMonday, January 23, 2017

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, November 2, 2016
Primary Code044
First Use Anywhere DateMonday, January 23, 2017
First Use In Commerce DateMonday, January 23, 2017

Trademark Owner History


Party NameBioNTech US Inc.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Party NameNeon Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Party NameNeon Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Party NameNeon Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Trademark Events


Event DateEvent Description
Monday, July 10, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, June 3, 2022NEW CERTIFICATE UNDER SECTION 7 ¿ PROCESSED
Thursday, June 2, 2022CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, January 6, 2022TEAS SECTION 7 REQUEST RECEIVED
Tuesday, July 10, 2018REGISTERED-PRINCIPAL REGISTER
Tuesday, June 5, 2018NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Saturday, June 2, 2018ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, May 31, 2018STATEMENT OF USE PROCESSING COMPLETE
Monday, May 21, 2018USE AMENDMENT FILED
Thursday, May 31, 2018DIVISIONAL PROCESSING COMPLETE
Monday, May 21, 2018DIVISIONAL REQUEST RECEIVED
Wednesday, May 30, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, May 21, 2018TEAS REQUEST TO DIVIDE RECEIVED
Monday, May 21, 2018TEAS STATEMENT OF USE RECEIVED
Monday, May 21, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, May 21, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, November 21, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 26, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 26, 2017PUBLISHED FOR OPPOSITION
Wednesday, September 6, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, August 12, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, August 11, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, August 7, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, August 7, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, August 7, 2017TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, February 6, 2017NOTIFICATION OF PRIORITY ACTION E-MAILED
Monday, February 6, 2017PRIORITY ACTION E-MAILED
Monday, February 6, 2017PRIORITY ACTION WRITTEN
Monday, February 6, 2017ASSIGNED TO EXAMINER
Wednesday, November 2, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, November 1, 2016NEW APPLICATION ENTERED